OTCPK:CHMMF (Australia)
Ordinary Shares
$
0.00
-0.029 (-96.67%)
10:09 PM EST
Business Description
Chimeric Therapeutics Ltd
ISIN : AU0000121576
Share Class Description:
CHMMF: Ordinary SharesDescription
Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. Primary products under development by the company are NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company has one segment being the research, development and commercialization of health technologies.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.16 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | 140 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.32 | |||||
| Quick Ratio | 0.32 | |||||
| Cash Ratio | 0.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -84.28 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -170.91 | |||||
| ROA % | -58.43 | |||||
| ROIC % | -128.01 | |||||
| ROC (Joel Greenblatt) % | -8198.21 | |||||
| ROCE % | -124.56 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.67 | |||||
| EV-to-EBIT | -0.78 | |||||
| EV-to-Forward-EBIT | -0.86 | |||||
| EV-to-EBITDA | -0.78 | |||||
| EV-to-Forward-EBITDA | -0.71 | |||||
| EV-to-FCF | -1.25 | |||||
| Earnings Yield (Greenblatt) % | -128.21 | |||||
| FCF Yield % | -60.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CHMMF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Chimeric Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.012 | ||
| Beta | 0 | ||
| Volatility % | 140 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000992 | ||
| 20-Day SMA ($) | 0.01405 | ||
| 12-1 Month Momentum % | 140 | ||
| 52-Week Range ($) | 0.001 - 0.035 | ||
| Shares Outstanding (Mil) | 893.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chimeric Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chimeric Therapeutics Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chimeric Therapeutics Ltd Frequently Asked Questions
What is Chimeric Therapeutics Ltd(CHMMF)'s stock price today?
The current price of CHMMF is $0.00. The 52 week high of CHMMF is $0.04 and 52 week low is $0.00.
When is next earnings date of Chimeric Therapeutics Ltd(CHMMF)?
The next earnings date of Chimeric Therapeutics Ltd(CHMMF) is .
Does Chimeric Therapeutics Ltd(CHMMF) pay dividends? If so, how much?
Chimeric Therapeutics Ltd(CHMMF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers